Completed Studies:
  
Investigation of the potential for indole-3-carbinol to prevent aflatoxin B1-induced liver cancer in rats. 
I3C was found to protect against tumour formation whether give two weeks before or six weeks after treatment with AFB1 commenced.
  Investigation of the ability of isoflavanoids and lignans in soya to interfere with the transduction of cellular signals which might promote breast cancer. In this work the effects of genistein, equol, enterodiol and enterolactone on the growth of human breast cancer cells and on mitogen- or tumour promotor-induced early response gene expression were assessed.
  
In a clinical pilot study of a turmeric extract curcuminoids were found to be safe, but curcumin was not detected in plasma. A curcumin conjugate was identified in faeces. Levels of inducible COX-2 or malonaldehyde DNA adducts in blood of recipients were not affected by curcumin.
  
In a search for putative cancer chemopreventive constituents of brown rice bran, several potentially beneficial molecules were characterised on the basis of their ability to interfere with proliferation of human-derived breast and colon cancer cells. Most interesting among these agents is the flavone tricin.
Ongoing Studies:
   
Development of new mass spectrometric techniques to detect chemopreventive agents, including curcumin, I3C, tricin and resveratrol, and their metabolites.
       
Exploration of mechanisms of cancer chemoprevention by curcumin, a constituent of turmeric, which prevents colon cancer in rodents, particularly with respect to inhibition of the activity of the transcription factor NF- which upregulates many genes involved in the proinflammatory response and in cell survival. Curcumin behaves in some ways like the anti-inflammatory drug aspirin.
Raw turmeric
              Raw turmeric
        
Unravelling of the relationship between efficacy and pharmacokinetics of curcumin in Min mice (a model of adenomatous polyposis coli, a severe preneoplastic condition that, in humans, predisposes individuals to colon cancer). Elucidation of the metabolism of curcumin in humans and rodents, in vitro, in tissue preparations, and in vivo.
Curcumin powder
               Curcumin powder
     Clinical pharmacokinetic and pharmacodynamic evaluation of a Curcuma extract in colorectal cancer patients. Clinical studies are underway with a high dose formulation which will establish how curcumin is altered by, and excreted from, the body.
     Investigation of the mechanism of action of indole-3-carbinol in breast cancer cells with respect to induction of apoptosis and signalling through the PI3kinase/Akt survival pathway.
     Elucidation of the pharmacokinetic profile of indole-3-carbinol (I3C) and of its acid condensation products, and their chemotherapeutic/chemopreventive potential in cells and animal models. Measurement of blood and tissue levels of I3C and the condensation products formed on contact with stomach acid using a newly established HPLC method.
     Characterisation of the efficacy in vivo and the pharmacological properties of the brown rice constituent tricin.
     Development of a novel method to detect and quantitate 8-hydroxy deoxyguanosine as a sensitive indicator of oxidative damage in DNA. This method can be used to establish the pharmacodynamic potency of novel cancer chemopreventive agents with antioxidant properties.
     Investigation of a resveratrol analogue DMU 212 (collaboration with De Montfort University).

 

 
  | The  GroupOncology in Leicester  | Why Chemoprevention  |  Mechanisms  Section
| Biomonitoring Section  |  Pharmacology Section  |  Achievements  | News |  References  |  Contacts